Home/Filings/4/0001618835-22-000030
4//SEC Filing

File Justin J. 4

Accession 0001618835-22-000030

CIK 0001618835other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:06 PM ET

Size

7.1 KB

Accession

0001618835-22-000030

Insider Transaction Report

Form 4
Period: 2022-02-18
File Justin J.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-02-18+450,000810,982 total
  • Award

    Stock option (right to buy)

    2022-02-18+450,000450,000 total
    Exercise: $0.49Exp: 2032-02-18Common Stock (450,000 underlying)
Footnotes (2)
  • [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022.
  • [F2]The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022.

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1
  • filerCIK 0001726277

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:06 PM ET
Size
7.1 KB